Cargando…

Luminal B breast tumors are not HER2 positive – authors' response

Detalles Bibliográficos
Autores principales:	Tamimi, Rulla M, Schnitt, Stuart J, Colditz, Graham A, Collins, Laura C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614507/ http://dx.doi.org/10.1186/bcr2141

Ejemplares similares

Luminal B breast tumors are not HER2 positive
por: Bhargava, Rohit, et al.
Publicado: (2008)

Columnar cell lesions and subsequent breast cancer risk: a nested case-control study
por: Aroner, Sarah A, et al.
Publicado: (2010)

Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers
por: Yaghjyan, Lusine, et al.
Publicado: (2015)

Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case–control study
por: Tamimi, Rulla M, et al.
Publicado: (2005)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Beca, Francisco, et al.
Publicado: (2021)

Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk
por: Liu, Ying, et al.
Publicado: (2013)

Androgen Receptor Expression in Breast Cancer in Relation to Molecular Phenotype: Results from the Nurses’ Health Study
por: Collins, Laura C., et al.
Publicado: (2011)

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
por: Tamimi, Rulla M, et al.
Publicado: (2008)

EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies
por: Beca, Francisco, et al.
Publicado: (2017)

Association and Prediction Utilizing Craniocaudal and Mediolateral Oblique View Digital Mammography and Long-Term Breast Cancer Risk
por: Chen, Simin, et al.
Publicado: (2023)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Spontaneous Epithelial-Mesenchymal Transition and Resistance to HER-2-Targeted Therapies in HER-2-Positive Luminal Breast Cancer
por: Lesniak, David, et al.
Publicado: (2013)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
por: Rajc, Jasmina, et al.
Publicado: (2018)

Breast cancer susceptibility loci and mammographic density
por: Tamimi, Rulla M, et al.
Publicado: (2008)

Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue
por: Oh, Hannah, et al.
Publicado: (2017)

High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case–control study
por: Tamimi, Rulla M, et al.
Publicado: (2004)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

HER2 status and disparities in luminal breast cancers
por: Holowatyj, Andreana N., et al.
Publicado: (2016)

Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer
por: Oh, Hannah, et al.
Publicado: (2016)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98
por: Kensler, Kevin H., et al.
Publicado: (2019)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009)

Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women
por: Berkey, Catherine S., et al.
Publicado: (2020)

Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer
por: Vellal, Adithya D, et al.
Publicado: (2021)

High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer
por: Lee, Seung Eun, et al.
Publicado: (2019)

Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
por: Utsumi, Toshiaki, et al.
Publicado: (2021)

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
por: Poorvu, Philip D., et al.
Publicado: (2020)

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Modulating cancer stemness provides luminal a breast cancer cells with HER2 positive-like features
por: Mei, Yi, et al.
Publicado: (2020)

Single nucleotide polymorphisms and breast cancer: not yet a success story
por: Tamimi, Rulla M
Publicado: (2006)

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay
por: Desai, Neelam V., et al.
Publicado: (2018)

Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases
por: Izutsu, Nobuyuki, et al.
Publicado: (2021)

Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer
por: Lv, Ji, et al.
Publicado: (2022)

Correlation between Androgen Receptor Expression in Luminal B (HER–2 Negative) Breast Cancer and Disease Outcomes
por: Yang, Fan, et al.
Publicado: (2022)

Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database
por: Nahleh, Zeina A, et al.
Publicado: (2020)

Androgen receptor expression in normal breast tissue and subsequent breast cancer risk
por: Kensler, Kevin H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8rgg4i812v4jn7oqe7d1pvkld0